Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsWages, Salaries and Other
Ratios

Surgery Partners (SGRY) Depreciation & Amortization (IS): 2014-2025

Historic Depreciation & Amortization (IS) for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $39.5 million.

  • Surgery Partners' Depreciation & Amortization (IS) fell 2131.47% to $39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $156.4 million, marking a year-over-year increase of 188.93%. This contributed to the annual value of $152.6 million for FY2024, which is 2921.25% up from last year.
  • Latest data reveals that Surgery Partners reported Depreciation & Amortization (IS) of $39.5 million as of Q3 2025, which was down 2131.47% from $40.3 million recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Depreciation & Amortization (IS) peaked at $50.2 million during Q3 2024, and registered a low of $22.7 million during Q4 2021.
  • In the last 5 years, Surgery Partners' Depreciation & Amortization (IS) had a median value of $29.8 million in 2022 and averaged $31.6 million.
  • As far as peak fluctuations go, Surgery Partners' Depreciation & Amortization (IS) soared by 7370.24% in 2024, and later tumbled by 2131.47% in 2025.
  • Over the past 5 years, Surgery Partners' Depreciation & Amortization (IS) (Quarter) stood at $22.7 million in 2021, then skyrocketed by 30.4% to $29.6 million in 2022, then increased by 5.07% to $31.1 million in 2023, then rose by 9.0% to $33.9 million in 2024, then grew by 16.52% to $39.5 million in 2025.
  • Its Depreciation & Amortization (IS) was $39.5 million in Q3 2025, compared to $40.3 million in Q2 2025 and $36.3 million in Q1 2025.